By Industry
Bio & Healthcare
We advise in the language of the industry at the intersection of clinical trials, regulatory approval, and technology transfer.
A biotech company's value shifts depending on the stage of its pipeline, and contract terms must move accordingly. Rion designs contract milestones based on clinical timelines and regulatory approval procedures.
In technology transfer negotiations, it is not only the payment structure but also development obligations and termination conditions that determine the real risk. We sort out these clauses first, early in the negotiation.
- 01Technology transfer and licensing agreements
- 02Clinical trial agreement review
- 03Regulatory approval advisory
- 04Medical device regulatory response
- 05R&D collaboration agreement design